ISPE Good Practice GuidesISPE Good Practice Guides (GPGs) provide information or advise on a particular topic area and explain underlying technical principles and suggest solutions in an area where no single answer is correct and where several outcomes may be possible. GPGs address technical areas related to facilities and pharmaceutical manufacturing, and may highlight topics that propose how to meet the intent of a specific aspect of a GMP. ![]() ISPE Good Practice Guide: Development of Investigational Therapeutic Biological Products
Published: August 2007 With the rapid growth in the biopharmaceutical industry over the past two decades, the number of newly approved biological products has dramatically increased. In 2005, a record 21 biological products received US Food and Drug Administration (FDA) approvals, including therapies for the treatment of rheumatoid arthritis, diabetes, cancer, and rare genetic disorders. With the increasing number of approved biological products on the global market come major challenges for many biopharmaceutical companies, especially during the critical process development and manufacturing stages of product development. This Guide will consider the major issues that will confront a biopharmaceutical company in moving therapeutic biological products from the laboratory to the clinic and beyond. The Guide is intended to provide readers with an understanding of issues surrounding product and process development, manufacturing, investigational product supply chain management, quality control/quality assurance, and global regulatory requirements for biopharmaceuticals. The intended audience for this Guide includes the following disciplines:
The Guide specifically addresses the methods and challenges surrounding recombinant therapeutic biological product development, including considerations during its use in clinical trials. It focuses on project planning/management, preclinical/clinical phases, comparability and bridging studies, Active Pharmaceutical Ingredient (API)/Drug Substance (DS)/Drug Product (DP)/placebo process development, manufacturing of DS/DP, process validation, supply chain management of biological investigational products for clinical trials, quality control/quality assurance considerations, and global regulatory strategies. The regulations and guidelines from the US, EU, Canada, Japan, and ICH have been considered in the development of this Guide. While not in the scope of this Guide, it is recognized that the development of other biologics (e.g., cellular and gene therapy) may require additional considerations for their successful product development from the laboratory to the clinic. How to buy:
![]() ISPE Good Practice Guide: Commissioning and Qualification of Pharmaceutical Water and Steam Systems
Published: February 2007 Work smarter, not harder, when it comes to the commissioning and qualification of your pharmaceutical water and steam systems. This Guide will show you how to change your focus from a “qualify everything” approach, to a more efficient and cost-effective risk-based evaluation of individual system components or process steps. The ISPE Good Practice Guide: Commissioning and Qualification of Pharmaceutical Water and Steam Systems provides an alternative approach, based on “risk assessment” principles and “process understanding” for the commissioning and qualification of direct impact water and steam systems. Specifically, this Guide:
The Guide, intended as a supplement to the ISPE Baseline® Guide on Commissioning and Qualification, aims to apply the principles discussed in the ISPE Baseline® Guide to direct water and steam systems. How to buy:
![]() ISPE Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment
Published: September 2005 This ISPE Good Practice Guide provides a standard methodology for use in testing the containment efficiency of solids handling systems used in the pharmaceutical industry under closely defined conditions. It covers the main factors that affect the test results for specific contained solids handling systems, including material handled, room environment, air quality, ventilation and operator technique. How to buy:
![]() ISPE Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment Bound / Electronic Set
The electronic version of the ISPE Good Practice Guide features enhanced capabilities including bookmarks and links from the Guide’s Table of Contents for easy access to all sections of the electronic document, as well as pages (thumbnails) for simplicity of navigation. The electronic version is an accurate reproduction of the printed Guide, which is searchable and provided on CD-ROM for portability. The bound / electronic set includes one bound version of the Guide, and one CD containing a PDF document** of the Guide.
** System requirements and user information for the electronic document. ![]() ISPE Good Practice Guide: Technology Transfer
How to buy:
The ISPE Good Practice Guide: Technology Transfer is used in association with ISPE training courses Technology Transfer for Active Pharmaceutical Ingredients and Technology Transfer for Finished Dosage Forms, Oral Solids and Sterile Liquids. Attendees of the training course receive a complimentary copy of this publication.
ISPE Good Practice Guide: Technology Transfer Bound / Electronic Set
The electronic version of the ISPE Good Practice Guide features enhanced capabilities including bookmarks and links from the Guide’s Table of Contents for easy access to all sections of the electronic document, as well as pages (thumbnails) for simplicity of navigation. The electronic version is an accurate reproduction of the printed Guide, which is searchable and provided on CD-ROM for portability. The bound / electronic set includes one bound version of the Guide, and one CD containing a PDF document** of the Guide.
** System requirements and user information for the electronic document. ![]() ISPE Good Practice Guides Under DevelopmentGood Engineering Practice Heating, Ventilation, and Air Conditioning (HVAC) Science and Risk-Based Cleaning Process Development and Validation
These activities develop scientific knowledge of cleaning processes and are ultimately linked to the protection of the patient. Cold Chain Management
Goal is to provide practical guidance in the area of cold chain management, with examples of typical documents.
Direct Impact Process Gas Systems
Pharmaceutical Testing Laboratories ![]()
Page last updated: 27 August 2008 |
Web Site Sponsors |
|||